HEALTHSTAT NEWS
Opinion: Who benefits from classifying obesity as a disease?
The article discusses how drugmakers like Eli Lilly and Novo Nordisk promote classifying obesity as a chronic disease to justify long-term medical treatments. They cite the World Health Organization's recognition of obesity as a disease, aiming to frame it as a medical problem requiring pharmaceutical solutions.
Mentioned
Related Signal
Adjacent reporting
- Obesity doesn’t equate to ill health: why the ‘disease’ label doesn’t always fit
- STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
- France to partially reimburse weight-loss drugs for obesity patients
- The real reason you're not getting skinny on weight-loss drugs like Ozempic and Wegovy... as scientists also discover who is most at risk for undesirable side effects
- An obesity drug deep-dive, and peptides move mainstream